Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Adebrelimab Plus Chemo and Recaticimab in Perioperative Treatment of Resectable NSCLC
Phase 2
Recruiting
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2024-06-21
- Last Posted Date
- 2024-12-16
- Target Recruit Count
- 35
- Registration Number
- NCT06467617
- Locations
- 🇨🇳
Beijing Chest Hospital, Beijing, Beijing, China
PD-L1/PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLC
Phase 2
Not yet recruiting
- Conditions
- Limited-stage Small-cell Lung Cancer
- Interventions
- First Posted Date
- 2024-04-19
- Last Posted Date
- 2024-04-19
- Target Recruit Count
- 60
- Registration Number
- NCT06375109
News
No news found